EOM Pharmaceuticals Holdings, Inc.

IMUC · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$1,892-$1,613-$2,647-$2,679
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$345$493$379$333
Other Non-Cash-$443-$302-$355$40
Operating Cash Flow-$2,680-$1,422-$2,623-$2,306
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$2,500$1,087$1,750$2,501
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1,029
Financing Cash Flow$2,500$1,087$1,750$3,530
Forex Effect$0$0$0$0
Net Chg. in Cash-$180-$335-$873$1,224
Supplemental Information
Beg. Cash$278$613$1,487$263
End Cash$99$278$613$1,487
Free Cash Flow-$2,680-$1,422-$2,623-$2,306